
|Videos|October 17, 2017
Practical Advice for Giving Back
Advertisement
Episodes in this series

Newsletter
Stay up to date on cancer updates, research and education
SubscribeAdvertisement
Related to this article

Three doctors dismissed Christine Kushner’s breast changes at 37. Trusting her gut and pushing for a mammogram helped save her life.

Five CURE bloggers living with breast cancer share what Breast Cancer Awareness Month can miss, from metastatic disease to men and mammogram limits.

A study of 39,184 people with solid tumors, published Oct. 8, 2026, found that about 1 in 6 had an inherited genetic change that increased their cancer risk. Testing only people under 50 would have missed 72% of those with these changes.

In a trial of 2,175 people with early HER2-positive breast cancer, 43.8% had no invasive cancer left after 12 weeks of a lighter regimen, and certain tumor features predicted who was most likely to respond.

Median progression-free survival reached 24.9 months with Tukysa plus Herceptin and Perjeta versus 16.3 months with placebo plus Herceptin and Perjeta.

Breast cancer survivor Sue Weldon discusses survivorship gaps, integrative therapies alongside treatment and why caregivers should prioritize themselves.
Advertisement
Advertisement









